Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimiracetam for HIV-Associated Neuropathic Pain
NCT01135251Phase 2Completed
- Sponsor
- Neurotune AG
- Start
- Oct 2009
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dimiracetam in antiretroviral toxic neuropathy (ATN), sponsored by Neurotune AG. Started Oct 2009; status: completed.
02
Drugs
dimiracetam
03
Conditions
antiretroviral toxic neuropathy (ATN)
Beyond the preview
Go deeper on NCT01135251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01135251.